Texas is currently home to 4879 active clinical trials, seeking participants for engagement in research studies. These trials take place at a variety of cities in the state, including Houston, Dallas, San Antonio and Austin. Whether you're a healthy volunteer interested in paid medical research or someone seeking trials related to a specific condition, the state offers a diverse array of opportunities in your vicinity.
Determination and Validation of a Multi-analyte Assay for Lung Cancer Screening
Recruiting
This study is part of the development and validation of a non-invasive lung screening test which aim to identify early stage lung cancer in patients at high risk for lung cancer.
Gender:
ALL
Ages:
Between 50 years and 80 years
Trial Updated:
03/28/2024
Locations: Michael E. DeBakey VA Medical Center, Houston, Texas
Conditions: Lung Cancer
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia
Recruiting
This phase II trial studies the side effects and how well combination chemotherapy works in treating patients with acute lymphoblastic leukemia, lymphoblastic lymphoma, Burkitt lymphoma/leukemia, or double-hit lymphoma/leukemia that has come back or does not respond to treatment. Drugs used in chemotherapy, such as clofarabine, etoposide, cyclophosphamide, vincristine sulfate liposome, dexamethasone and bortezomib, work in different ways to stop the growth of tumor cells, either by killing the c... Read More
Gender:
ALL
Ages:
15 years and above
Trial Updated:
03/28/2024
Locations: M D Anderson Cancer Center, Houston, Texas
Conditions: Recurrent Acute Lymphoblastic Leukemia, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Burkitt Leukemia, Recurrent Burkitt Lymphoma, Recurrent Childhood Lymphoblastic Lymphoma, Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements, Refractory Acute Lymphoblastic Leukemia, Refractory Burkitt Leukemia, Refractory Burkitt Lymphoma, Refractory High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements, Refractory Lymphoblastic Lymphoma
Volume Outcome Relationships and Effects
Recruiting
This is a retrospective analysis to assess if high-volume hospital facilities experience greater or lesser rates of incidence in patients with esophageal cancer than low-volume facilities.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
03/26/2024
Locations: Methodist Richardson Medical Center, Richardson, Texas
Conditions: Esophageal Cancer
Physician-Nurse Dyad Rounding: A Collaborative Approach to Improve Unit-Level Metrics
Recruiting
The project will be implemented on one unit at a time until the co-rounding process has been implemented on each Medical-Surgical unit. This study will involve the geo-localized hospitalist on the designated unit and the nursing staff involved in clinical patient care
Gender:
ALL
Ages:
All
Trial Updated:
03/26/2024
Locations: Clinical Research Institute at Methodist Health System, Dallas, Texas
Conditions: Wellness, Psychological
Pelvic Angioembolization: A Prospective Multi-Institutional Study (Data From All Campuses Will be Used)
Recruiting
The investigator's propose a multicenter prospective observational study to investigate the use of embolization in patients with negative angiogram and to ascertain the optimal level of treatment when the angiogram is positive; non-selective vs. selective embolization.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
03/26/2024
Locations: Methodist Dallas Medical Center, Dallas, Texas
Conditions: Pelvic Hemorrhage
Perceived Coping, Meaning, and Joy at Work
Recruiting
The aim of this study is to assess and describe employee characteristics associated with perceived horizontal inter-collegial workplace uncivil behavior within nursing services, and identify any relationships with meaning and joy in work (MJW), and assess job satisfaction.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
03/26/2024
Locations: Methodist Richardson Medical Center, Richardson, Texas
Conditions: Undefined
Safety and Efficacy of Endoscopic Ultrasound-Guided Portal Pressure Gradient Measurement
Recruiting
The purpose of this study is to evaluate the efficacy, safety, and adequacy of Endoscopic Ultrasound (EUS) Portal Pressure Gradient Measurement (PPGM) in patients undergoing EUS-guided liver biopsies.
Gender:
ALL
Ages:
Between 18 years and 85 years
Trial Updated:
03/26/2024
Locations: Methodist Dallas Medical Center, Dallas, Texas
Conditions: Liver Diseases
Antimicrobial Resistance During the SARS-CoV-2 (COVID-19) Pandemic
Recruiting
Assess the incidence and rates of resistant pathogens prior to and during the COVID-19 pandemic.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
03/26/2024
Locations: Methodist Dallas Medical Center, Dallas, Texas
Conditions: COVID-19
Analysis of Donor-derived Cell Free DNA in Liver Transplant Patients
Recruiting
Determine the levels of Donor-derived (dd)cell-free DNA(cfDNA )in liver transplant recipients with normal liver function tests (LFTs) indicating stable immunosuppression status (IS). Based on this range use the dd-cfDNA levels to determine over or under IS in liver transplant patients to make changes to their IS medication regimen.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
03/26/2024
Locations: Methodist Dallas Medical Center, Dallas, Texas
Conditions: Liver Transplant Failure
Clopidogrel Hyper-Responsiveness: Incidence and Associated Outcomes in Patients With Cerebral Aneurysms
Recruiting
This registry study will investigate the incidence of and outcomes associated with clopidogrel hyper-responsive patients treated at Methodist Dallas Medical Center, beginning in January 2018, who suffered cerebral aneurysms.
Gender:
ALL
Ages:
Between 18 years and 85 years
Trial Updated:
03/26/2024
Locations: Methodist Dallas Medical Center, Dallas, Texas
Conditions: Cerebral Aneurysm
Hepatic Transplantation Registry
Recruiting
The objective is to provide a mechanism to store information regarding the demographic characteristics; pre-, intra-, and post-transplant laboratories; treatment strategies; complications; and outcomes in patients undergoing hepatic transplantation.
Gender:
ALL
Ages:
Between 18 years and 75 years
Trial Updated:
03/26/2024
Locations: Methodist Dallas Medical Center, Dallas, Texas
Conditions: Identify More Accurate Predictive Models of Transplant Risk to Monitor and Evaluate New and Existing Patient Factors
Outcomes Using MARS for Patients With ALF
Recruiting
Retrospective chart review will be conducted on patients at Methodist Dallas Medical Center, meeting the inclusion criteria from January 1, 2019 to December 15, 2020 to determine the transplant free survival and overall survival and other secondary outcome measures.
Gender:
ALL
Ages:
All
Trial Updated:
03/26/2024
Locations: Methodist Dallas Medical Center, Dallas, Texas
Conditions: Alcoholic Hepatitis, Acute Liver Failure